Skip to main content

Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.

Publication ,  Journal Article
Armstrong, PW; Collen, D
Published in: Circulation
June 19, 2001

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 19, 2001

Volume

103

Issue

24

Start / End Page

2987 / 2992

Location

United States

Related Subject Headings

  • Thrombin
  • Sex Factors
  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Plasminogen Activators
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Male
  • Intracranial Hemorrhages
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., & Collen, D. (2001). Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2. Circulation, 103(24), 2987–2992. https://doi.org/10.1161/01.cir.103.24.2987
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.Circulation 103, no. 24 (June 19, 2001): 2987–92. https://doi.org/10.1161/01.cir.103.24.2987.
Armstrong, P. W., and D. Collen. “Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 2.Circulation, vol. 103, no. 24, June 2001, pp. 2987–92. Pubmed, doi:10.1161/01.cir.103.24.2987.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

June 19, 2001

Volume

103

Issue

24

Start / End Page

2987 / 2992

Location

United States

Related Subject Headings

  • Thrombin
  • Sex Factors
  • Risk Factors
  • Platelet Aggregation Inhibitors
  • Plasminogen Activators
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Male
  • Intracranial Hemorrhages
  • Humans